Wang Xue, Geng Shitao
Department of Oncology, First People's Hospital of Guangyuan, Guangyuan, China.
Department of Emergency, First Naval Hospital of Southern Theater Command, Zhanjiang, China.
Front Oncol. 2023 Mar 24;13:1138362. doi: 10.3389/fonc.2023.1138362. eCollection 2023.
The gut microbiome is involved in the absorption and metabolism of host nutrients and modulates the immune response, affecting the efficacy of immunotherapy for cancer. In patients receiving immunotherapy, appropriate modifications of gut microbiota are thought to improve therapeutic response. Of all the factors that influence the gut microbiota, diet is the most influential and modifiable. Healthy dietary patterns as well as some specific dietary components can help the growth of beneficial microbiota in the gut, thereby protecting against cancers and promoting human health. A growing number of researches have confirmed the positive effects of a diet-gut microbiota approach as an adjuvant therapy for cancer, but controversy remains. Here, we summarize the interactions between diet and gut microbes based on previous studies, and discuss the role of gut microbiota-based dietary strategies in tumor immunotherapy, with the potential mechanisms of actions also intensively discussed.
肠道微生物群参与宿主营养物质的吸收和代谢,并调节免疫反应,影响癌症免疫治疗的疗效。在接受免疫治疗的患者中,适当改变肠道微生物群被认为可以改善治疗反应。在所有影响肠道微生物群的因素中,饮食是最具影响力且可改变的。健康的饮食模式以及一些特定的饮食成分有助于肠道中有益微生物群的生长,从而预防癌症并促进人类健康。越来越多的研究证实了饮食-肠道微生物群方法作为癌症辅助治疗的积极作用,但仍存在争议。在此,我们基于先前的研究总结饮食与肠道微生物之间的相互作用,并讨论基于肠道微生物群的饮食策略在肿瘤免疫治疗中的作用,同时也深入探讨其潜在作用机制。